Inactivation of Cancer Mutations Utilizing CRISPR/Cas9.
Gebler C, Lohoff T, Paszkowski-Rogacz M, Mircetic J, Chakraborty D, Camgoz A, Hamann MV, Theis M, Thiede C, Buchholz F.
Gebler C, et al. Among authors: mircetic j.
J Natl Cancer Inst. 2016 Aug 30;109(1):djw183. doi: 10.1093/jnci/djw183. Print 2017 Jan.
J Natl Cancer Inst. 2016.
PMID: 27576906
Free PMC article.